Turkey ÜTS registration ae48c7d3bb7063202f2b96792ff66e5a
XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS
TR: XGEVA 120 MG SC ENJEKSİYONLUK ÇÖZELTİ, 4 ADET
Turkey·Pharmaceutical Product·AMGEN İLAÇ TİC. LTD. ŞTİ.·Licensed Aug 23, 2022License details
- Product ID (UID)
- ae48c7d3bb7063202f2b96792ff66e5a
- License Number
- 2022/469
- Barcode
- 8699862770132
- ATC Code
- M05BX04
License holder information
- License Holder
- AMGEN İLAÇ TİC. LTD. ŞTİ.
Active ingredient & license information
- Active Ingredient (EN)
- Denosumab
- License Date
- Aug 23, 2022
About this record
Access comprehensive regulatory information for XGEVA 120 MG SC SOLUTION FOR INJECTION, 4 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number ae48c7d3bb7063202f2b96792ff66e5a with license number 2022/469and contains active ingredient Denosumab . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI21,000+ Products